239
Views
1
CrossRef citations to date
0
Altmetric
Articles

Preparation and characterization of a novel Fe3O4@PAA@MIL-100(Cr) metal-organic framework for the drug delivery of ciprofloxacin and investigation of its antibacterial activities

, &
Pages 1318-1324 | Received 21 Aug 2021, Accepted 16 Jan 2022, Published online: 03 Mar 2022
 

Abstract

Metal-organic frameworks are important materials for drug delivery and imaging applications due to their easy surface modifications and porous surfaces. In this work, we used Fe3O4@PAA@MIL-100(Cr) MOF as a carrier of ciprofloxacin (CIP). Fourier-transform infrared spectroscopy (FT-IR), ultraviolet-visible spectroscopy (UV-Visible), energy-dispersive X-ray spectroscopy (EDAX), X-ray diffraction (XRD), Brunauer-Emmett-Teller (BET), and scanning electron microscope (SEM) analysis confirmed the encapsulation of the drug in nanocarrier. The result of this study showed that ciprofloxacin as an antibacterial drug was encapsulated in Fe3O4@PAA@MIL-100(Cr) with a drug loading of 50 wt %. Moreover, drug release was done at pH: 7.4 and pH: 5.5 within 3 days which resulted in about 80% release of the drug at pH: 7.4. In addition, the release analysis based on kinetic equations revealed satisfactory results. The surprising antibacterial activities of Fe3O4@PAA@MIL-100(Cr) and Fe3O4@PAA@MIL-100(Cr)@CIP were tested against Escherichia coli and Staphylococcus aureus bacteria via the disk diffusion method.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Islamic Azad University, Qom Branch, Qom, I. R. Iran, followed by [grant number 2019-2898].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.